Rebecca Woodcock
Principal @ Yamaha Motor Ventures
San Francisco, United States
Rebecca Woodcock is a Principal at Yamaha Motor Ventures, investing in seed and Series A startups in the Health and Wellness space that are advancing human capabilities, preventing and reversing diseases, and enabling longer, more independent lives.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 62%
Last updated:
For AI agents: llms.txt
Industries Rebecca Woodcock invests in
Stages Rebecca Woodcock invests in
Countries Rebecca Woodcock invests in
Investment Focus
Industry
- Health Care 8 (62%)
- Medical 3 (23%)
- Medical Device 3 (23%)
- Advice 2 (15%)
- Banking 2 (15%)
Stage
- Seed 9 (69%)
- Angel 1 (8%)
- Series B 1 (8%)
- Convertible Note 1 (8%)
Country
- United States 9 (69%)
- Egypt 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Goodpath
|
Goodpath, a Cambridge, Ma.-based telehealth startup focused on improve helping people managing common health conditions, | $3.5M / Seed / Feb 27, 2021 | |
C. Light Technologies
|
C. Light is a neurotech company utilizing advanced machine learning and the most accurate commercially-available eye tracker (by 150X) to assess neurological health, starting with multiple sclerosis. it is a developer of a retinal eye-tracking platform used to improve the monitoring of neurodegenerative diseases. | $4.1M / Seed / Feb 02, 2021 | |
Siren Care
|
Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Siren significantly improves patient outcomes and experience by augmenting traditional healthcare with tech-enabled clinical models to provide whole person care. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive servicepowered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers. | $11.8M / Series B / May 27, 2020 | |
Memoir Health
|
Memoir Health was a healthcare services company that provided comprehensive, evidence-based care for chronic pain patients. Through AI-assisted clinical decision support, Memoir utilized a multidisciplinary approach to addresses the cognitive, sensory and functional dimensions of chronic pain. Memoir is now part of Lumeo Health. | Seed / Oct 31, 2018 | |
Shezlong
|
Shezlong is the first and largest online psychotherapy platform that aims to giving people convenient and private access to professional counseling in Arabic. Founded in 2016 with more than 350 therapists and 100 thousands clients. We primarily target Arab-speaking natives who are mostly allocated within the MENA region. However, Shezlong hasexperienced significant traction from Arabs all around the world, hitting 85 countries, and still growing exponentially!. Shezlong is the one-stop mental wellness shop that people seek to feel better. Starting from reading detailed and scientific blogs to get guidance, taking psychometric tests to assess their current state, receiving recommendations on the most relevant therapists for your case and booking a session, that's all Shezlong. We're with you 24x7, and we're part of our patients daily routine. And to do that, we empower therapists to become more successful and get closer to their patients! | $350K / Convertible Note / Apr 18, 2018 | |
Starship
|
Starship provides banking services. They also offer investment accounts and investment advisory services. The contact mode of the company is by mail, phone, and physical address. | Seed / Apr 18, 2018 | |
|
Siren Care
|
Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Siren significantly improves patient outcomes and experience by augmenting traditional healthcare with tech-enabled clinical models to provide whole person care. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive servicepowered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers. | Angel / Aug 02, 2016 | |
|
Siren Care
|
Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Siren significantly improves patient outcomes and experience by augmenting traditional healthcare with tech-enabled clinical models to provide whole person care. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive servicepowered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers. | Seed / Jul 01, 2016 | |
Ejenta
|
Ejenta is building an intelligent personal assistant platform, applied to several industry verticals, including space, government and healthcare. Ejenta's personal agent technology uses artificial intelligence to understand users’ daily activities, to monitor adherence to mission plans, and to offer personalized advice, coaching and support.Our agent technology is currently running 24/7 in NASA's Mission Control for the International Space Station.Ejenta's platform is based on exclusively licensed NASA technology and 20 years of research in human activity modeling, human-robot interaction, multi-agent systems and security. The platform integrates wearable and ambient sensors that gather real time behavior data, with a team of intelligent agents running in the cloud. Users can interact with their personal agents via mobile devices, Smart TVs and spoken natural language | Seed | |
Pilleve
|
Pilleve's aim is to fill in the gap between opioid prescription and addiction, which has affected millions of Americans and resulted in thousands of accidental overdoses.Pilleve decreases the costs of opioid abuse and addiction for insurance companies, providers, loved ones and patients. This ranges from accidental overdoses to long termtreatment. We do that by detecting the signs earlier, intervening, and ensuring patients are using their prescription opioids safely. In doing so, pilleve decreases the social and financial burden that cripples patients and their stakeholders. Pilleve’s solution to opioid misuse and abuse starts with an integrated pill bottle, coupled with a smartphone application, that accurately monitor’s a patient's intake in real time and securely holds opioids at all times. Patients input passwords or use their phone’s biometric scanners to dispense a pill. Before dispensing their opioids, patients are asked about their pain levels and mood in order to assess if they’re showings signs of aberrant behaviors. Pill usage data at the point of intake is collected and analyzed. Physicians are then alerted if a patient is exceeding recommended dosages. Through their EHRs, physicians can see results in real time and intervene by changing a patient’s prescription, limiting dosages, or helping patients wean off their medication. | Seed | |
| See all 13 investments → | |||
Co-Investors
About Yamaha Motor Ventures
Yamaha Motor Ventures & Laboratory Silicon Valley is a venture capital firm that invests in the robotics, food, and AgTech industry. The firm invests in early-stage companies that have product and customer validation.Yamaha Motor Ventures & Laboratory Silicon Valley (YMVSV) was founded in 2015 by Hiro Saijou and is headquartered in PaloAlto, California, United States.
Yamaha Motor Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anish Patel
Partner
|
|||
Keiichi Onishi
CEO & MANAGING DIRECTOR
|
|||
Nolan Paul
Partner
|
|||
|
Rebecca Woodcock
Principal
|
|||
Sean Simpson
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Rebecca Woodcock invest in?
Rebecca Woodcock invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Angel stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Rebecca Woodcock last invest?
The most recent investment recorded for Rebecca Woodcock closed in Feb 2021. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
